Cybin, Inc. (CLXPF)

1.64
0.00 0.01
OTC
Prev Close 1.64
Open 1.56
Day Low/High 1.55 / 1.66
52 Wk Low/High 0.19 / 2.23
Volume 221.92K
Exchange OTC
Shares Outstanding 14.20B
Market Cap 23.50M
Div & Yield N.A. (N.A)

Let's look at seven names that you can buy right now and watch grow.

This has given investors an opportunity to load up on small speculative names I love over the next 12 to 18 months.

There are much better places an investor can put their hard-earned cash, whether they want an aggressive or a moderate name.

The only companies that have Phase 2 clinical trials now are Compass Pathways, Mind Medicine, Cybin, and Mydecine Innovations.

Dealmaking is going strong and looks set to continue as mental health becomes a key investment theme going forward.